Thrombolytic therapy: new dimensions 2009.
Guha
Santanu
S
Department of Cardiology, Medical College, Kolkata, West Bengal, India. guhas55@hotmail.com
Mukherjee
Soura
S
Hema
M B
MB
D005343:Fibrinolytic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D006350:Heart Valve Prosthesis / Q000009:adverse effects; D006801:Humans; D020767:Intracranial Thrombosis / Q000188:drug therapy; D009203:Myocardial Infarction / Q000188:drug therapy; D016491:Peripheral Vascular Diseases / Q000188:drug therapy; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors; D011655:Pulmonary Embolism / Q000188:drug therapy; D015912:Thrombolytic Therapy / Q000379:methods / Q000639:trends; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use
D005343:Fibrinolytic Agents; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D010959:Tissue Plasminogen Activator